Accelerating Medical Research: The Bipartisan Quest for Cures
Monday, April 27, 2015 / 8:00 am - 9:15 am


Margaret Anderson, Executive Director, FasterCures, a Center of the Milken Institute

Joe Barton, U.S. Congressman, Texas
Francis Collins, Director, National Institutes of Health
Robert Hugin, Chairman and CEO, Celgene
Michael Milken, Chairman, Milken Institute
Sara Radcliffe, President and CEO, California Life Sciences Association

For all their many differences, Washington pundits and politicians frequently find common ground in the search for better therapies for our most devastating diseases. A rare bright spot of comity and bipartisanship, this shared interest in maintaining U.S. leadership in medical innovation presents several opportunities in 2015. From the 21st Century Cures legislation in Congress to the president's Precision Medicine Initiative to the FDA's next round of user fee negotiations, legislative and regulatory calendars are filling up with chances to advance science and help patients. Will 2015 bring the policy fixes needed to lower drug costs and increase patient input in the healthcare system? What can patients expect from Washington in the months ahead?